Salarius Pharmaceuticals Files 8-K
Ticker: DCOY · Form: 8-K · Filed: Jun 16, 2025 · CIK: 1615219
Sentiment: neutral
Topics: 8-k, other-events
Related Tickers: SLRX
TL;DR
SALARIUS PHARMA (SLRX) FILED AN 8-K ON 6/16 FOR AN EVENT ON 6/11 - DETAILS UNCLEAR.
AI Summary
Salarius Pharmaceuticals, Inc. filed an 8-K on June 16, 2025, reporting an event on June 11, 2025. The filing is categorized under 'Other Events' and does not provide specific details about the nature of the event in the provided text. The company is incorporated in Delaware and its principal executive offices are located in Houston, Texas.
Why It Matters
This filing indicates a material event has occurred for Salarius Pharmaceuticals, requiring public disclosure. Investors should look for further details to understand the implications.
Risk Assessment
Risk Level: medium — An 8-K filing signals a significant event, but the lack of specific details in this excerpt necessitates caution and further investigation.
Key Players & Entities
- Salarius Pharmaceuticals, Inc. (company) — Registrant
- June 11, 2025 (date) — Date of earliest event reported
- June 16, 2025 (date) — Date of Report
- Houston, TX (location) — Principal executive offices location
- Delaware (location) — State of incorporation
FAQ
What specific event is Salarius Pharmaceuticals reporting in this 8-K filing?
The provided text does not specify the nature of the 'Other Events' reported on June 11, 2025.
When was the 8-K report filed?
The 8-K report was filed on June 16, 2025.
What is the company's principal executive office address?
The company's principal executive offices are located at 2450 Holcombe Blvd. Suite X, Houston, TX 77021.
In which state is Salarius Pharmaceuticals incorporated?
Salarius Pharmaceuticals, Inc. is incorporated in Delaware.
What is the SEC file number for this filing?
The SEC file number for this filing is 001-36812.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 16, 2025 regarding Salarius Pharmaceuticals, Inc. (DCOY).